Zimmer Biomet
Yahoo Finance • yesterday
Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic
Company Logo The global medical robots market is projected to grow from USD 20.6 billion in 2026 to USD 41.7 billion by 2031, at a 15.1% CAGR. Growth is driven by demand for minimally invasive surgery, healthcare automation, precision pro... Full story
Yahoo Finance • 2 days ago
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now
Company Logo Players: Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker, Zimmer Biomet. Profile covers competitors, segments, regional shares, trends and opportunities. Minimally Invasive Robotic Surgical System MarketMinimally I... Full story
Yahoo Finance • 4 days ago
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine
Intuitive Surgical ISRG is focusing on Ambulatory surgery centers (ASCs) as an important channel for its robotic-surgery expansion. The company is targeting the low-cost ASC segment with refurbished XiR platforms priced below its flagship... Full story
Yahoo Finance • 4 days ago
How Far Could ISRG Stock Bounce From Here?
Image from Pixabay Intuitive Surgical (ISRG) stock could climb 23.9% to the April high it last fell back from, and you would risk about 5% to find out. That looks like a surgical-robot leader on sale, but the price history disagrees. Over... Full story
Yahoo Finance • 14 days ago
3 Cash-Producing Stocks We Find Risky
3 Cash-Producing Stocks We Find Risky Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.... Full story
Yahoo Finance • last month
The Hospital Bet That Reframes The Intuitive Surgical Stock Story
Photo by 127071 on Pixabay While investors fixate on a slowdown in current procedures, hospitals are accelerating their investment in the company's core platform, revealing a crucial, under-appreciated strength. When a market leader's st... Full story
Yahoo Finance • last month
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?
Zimmer Biomet ZBH appears well positioned for growth in the coming quarters, supported by healthy orthopedic procedure demand. Also, the company is experiencing strong adoption of Z1, HAMMR and OrthoGrid. Yet, intense competition and an el... Full story
Yahoo Finance • last month
Two Years Of Growth Barely Change What You Pay For Intuitive Surgical
Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly... Full story
Yahoo Finance • 2 months ago
Zimmer Biomet Q2 Earnings Call Highlights
Key Points Interested in Zimmer Biomet Holdings, Inc.? Here are five stocks we like better. Zimmer Biomet reported solid Q2 growth: Net sales rose 4.8% to $2.177 billion, driven by hips, specialty businesses and technology. Adjusted EPS w... Full story
Yahoo Finance • 2 months ago
Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook
Zimmer Biomet has reported Q2 revenues of around $2.18bn, denoting a year-over-year (YoY) uptick of 4.8%, and a revised full year outlook. Zimmer's knees segment was its strongest performer in Q2, with sales totalling $828.9m, followed by... Full story
Yahoo Finance • 2 months ago
ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market
Zimmer Biomet Holdings, Inc. ZBH posted second-quarter 2026 adjusted earnings per share of $2.07, which beat the Zacks Consensus Estimate of $2.01 by 2.99%. The adjusted figure was unchanged year over year. The quarter's adjustments inclu... Full story
Yahoo Finance • 2 months ago
3 Healthcare Stocks We Find Risky
3 Healthcare Stocks We Find Risky Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have re... Full story
Yahoo Finance • 2 months ago
Zimmer upgraded to Buy from Sell at UBS on growth and innovation
[Zimmer Biomet office in Mississauga, Ontario, Canada.] JHVEPhoto/iStock Editorial via Getty Images Zimmer Biomet (ZBH [https://seekingalpha.com/symbol/ZBH]) traded higher on Tuesday after UBS analyst Patrick Wood assumed its coverage and... Full story
Yahoo Finance • 2 months ago
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as... Full story
Yahoo Finance • 2 months ago
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More
Pre-Market Stock Futures: Futures are trading mixed after a wacky Monday that saw stocks soar on the open after the U.S. halted strikes on Iran following President Trump's decision to give the peace negotiations some room; however, the st... Full story
Yahoo Finance • 3 months ago
Intuitive, Globus, Teleflex named top picks as BMO initiates MedTech on buying opportunity
[Wall Street street sign in Manhattan financial district] Alexey_Fedoren BMO Capital Markets named Intuitive Surgical (ISRG [https://seekingalpha.com/symbol/ISRG]), Globus Medical (GMED [https://seekingalpha.com/symbol/GMED]), and Telefle... Full story
Yahoo Finance • 4 months ago
Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?
Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.'s share was trading at $87.27 as... Full story
Yahoo Finance • 4 months ago
3 Reasons to Sell ZBH and 1 Stock to Buy Instead
Over the past six months, Zimmer Biomet’s shares (currently trading at $85.45) have posted a disappointing 12.4% loss, well below the S&P 500’s 9.1% gain. This might have investors contemplating their next move. Is now the time to buy Zim... Full story
Yahoo Finance • 4 months ago
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The... Full story
Yahoo Finance • 5 months ago
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
[Magnifying Glass On Top Of Bar Chart] DNY59 Out of 22 S&P 500 healthcare companies that reported results this week, 19 beat earnings expectations and 15 posted year-over-year EPS growth. All 22 companies recorded year-over-year revenue i... Full story